COM:NEUMORATX
Neumora Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalswebsite
neumoratx.comcrunchbase
neumora-therapeuticslinkedin
neumorafounding date
Jan 01, 2019ipo date
Sep 15, 2023
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disord...Show More